Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, December 6, 2017
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Tue, December 5, 2017
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Matthew Luchini Initiated (BOLD) at Buy and Held Target at $35 on, Dec 5th, 2017
Matthew Luchini of BMO Capital, Initiated "Boundless Bio, Inc." (BOLD) at Buy and Held Target at $35 on, Dec 5th, 2017.
Matthew has made no other calls on BOLD in the last 4 months.
There are 4 other peers that have a rating on BOLD. Out of the 4 peers that are also analyzing BOLD, 2 agree with Matthew's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Josh Schimmer of "Evercore ISI Group" Downgraded from Buy to Hold on, Monday, October 16th, 2017
- Reni Benjamin of "Raymond James" Initiated at Hold on, Thursday, October 12th, 2017
These are the ratings of the 2 analyists that currently disagree with Matthew
- Raju Prasad of "William Blair" Initiated at Buy and Held Target at $35 on, Tuesday, October 17th, 2017
- Ying Huang of "B of A Securities" Maintained at Strong Buy with Increased Target to $33 on, Friday, September 22nd, 2017
